KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Retained Earnings (2016 - 2025)

Evolent Health (EVH) has 11 years of Retained Earnings data on record, last reported at -$886.2 million in Q3 2025.

  • For Q3 2025, Retained Earnings fell 64727.8% year-over-year to -$886.2 million; the TTM value through Sep 2025 reached -$886.2 million, down 64727.8%, while the annual FY2024 figure was -$1.8 million, 99.76% up from the prior year.
  • Retained Earnings reached -$886.2 million in Q3 2025 per EVH's latest filing, down from -$1.7 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$309000.0 in Q1 2021 and bottomed at -$886.2 million in Q3 2025.
  • Average Retained Earnings over 5 years is -$253.1 million, with a median of -$1.7 million recorded in 2025.
  • Peak YoY movement for Retained Earnings: tumbled 225360.07% in 2021, then soared 99.87% in 2022.
  • A 5-year view of Retained Earnings shows it stood at -$626.8 million in 2021, then surged by 99.81% to -$1.2 million in 2022, then plummeted by 60952.12% to -$719.2 million in 2023, then surged by 99.76% to -$1.8 million in 2024, then crashed by 50453.11% to -$886.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Retained Earnings were -$886.2 million in Q3 2025, -$1.7 million in Q2 2025, and -$1.7 million in Q1 2025.